Home Medicine Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
Article Open Access

Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy

  • Yan Hong , Jianyun Peng , Xiaoping Cai , Xiaoru Zhang , Yifei Liao and Lejian Lan EMAIL logo
Published/Copyright: October 5, 2017

Abstract

Objective

To evaluate the effect and toxicity of alprostadil combined with thioctic acid injection in the treatment of patients with diabetic nephropathy (DN).

Methods

Sixty two patients with DN were included in this study and randomly divided into control group (n=32) and experiment group (n=30). Patients in the control group were given alprostadil 20ug+NS 100ml ivgtt, qd and patients in the experiment group were given alprostadil 20ug+NS 100ml ivgtt combined with thioctic acid injection of 0.45g+100ml ivgtt, qd for 14 days. After treatment, the renal function and serum level of CRP, IL-6 and TNF-α were compared between the two groups.

Results

After two weeks of treatment, the serum level of CysC and UAER significant decreased for both control and experiment group with statistical difference of p<0.05. After treatment, the serum level of CysC were 1.40 ±0.46 mg/L and 1.02±0.33 for control and experiment group respectively (p<0.05). The post-treatment UAER in experiment group was significantly lower than those of control group with statistical difference (81.02±0.33 vs112.45±20.32, p<0.05) ug/min. The serum level of CRP, IL-6 and TNF-α were significantly decreased after treatment for both control and experiment group (p<0.05). And the post-treatment serum CRP, IL-6 and TNF-α in experiment group were significantly lower than those of control group with statistical difference (p<0.05). No significant side effects were found for the two groupsin the course of treatment.

Conclusion

Alprostadil combined with α-lipoic acid may improve renal function in patients with diabetic nephropathy by decreasing the levels of serum inflammatory factors.

1 Introduction

Diabetic nephropathy (DN) is a common chronic complication of diabetes, and this condition is the first etiological factor leading to end-stage renal disease in developed countries [1,2]. Inflammatory reactions and oxidative stress play a key role in renal injury related to DN [3-5]. It is also closely associated with disease progression, but the early onset of this diabetic complication is hidden, and disease progression cannot be controlled easily in the advanced stages. Therefore, DN should be detected and treated in the early stages. Alprostadil [6], α-lipoic acid [7,8], and other drugs can decrease the level of inflammatory cytokines in patients with DN and improve their renal functions. However, the combination of these drugs has been rarely reported. This study aimed to observe the effect of combined alprostadil-lipoic acid treatment on the renal functions and inflammatory cytokines of elderly patients who suffer from early DN.

2 Material and methods

2.1 Patients

Sixty two elderly patients who were diagnosed with early DN and admitted to the Nephrology Department of Lishui People’s Hospital from February 2015 to January 2017 were selected as study objects. Patients who satisfied the following criteria were included: age above 60 years; characteristics consistent with the diagnostic criteria presented by WHO in 1999; with signed informed consent and willingness to participate in the clinical study; and who were diagnosed with early DN in accordance with Mogensen’s DN staging criteria (UAER of 20–200μg/min or total urinary albumin for 24h of 30–300 mg). The following exclusion criteria were considered: uncontrolled or untreated acute or chronic infection, acute heart failure, gout, or ketoacidosis; systemic diseases or autoimmune diseases; and malignant tumors or bowel diseases. This study was approved by the ethical committee of Lishui People’s Hospital.

2.2 Treatment

The included 62 patients were randomly divided into two groups; a control group (n=32) and an experiment (n=30) group. Differences in gender, age, diabetic duration, blood sugar, serum creatinine, blood pressure, and other baseline data between the groups were not significant (P>0.05). All of the patients controlled their blood sugar through proper diet and insulin intake and their glycosylated hemoglobin was maintained at 5%–8%.The patients also used ACEI or ARB drugs to control the blood pressure. Patients in the control group were given alprostadil (Peking Detai Pharmaceutical Co., Ltd.) 20ug+NS 100ml ivgtt, qd and patients in the experiment group were given alprostadil 20ug+NS 100ml ivgtt combined with thioctic acid injection (YantaiZhichu Pharmaceutical Co., Ltd.) of 0.45g+100ml ivgtt, qd for 14 days.

2.3 Serum CysC, UAER, and SCr and inflammatory cytokines detection

Renal function indexes (CysC, UAER, and SCr) and inflammatory cytokines (IL-6, TNF-α, CRP) were compared between the two groups. Serum CysC was examined with an automatic biochemical analyzer. UAER was determined through radioimmunoassay, and serum IL-6 and TNF-α were detected through an enzyme linked immune sorbent assay. The tests were conducted in accordance with the manufacturers’ instructions.

2.4 Statistical analysis

STATA11.0 statistical software (http://www.stata.com) was used to do the data analysis. The measurement data were expressed with X ± S and the comparison between groups was made based on the t-test of the sample mean. The enumeration data were expressed with a relative number, and the comparison between groups was made based on the χ2 test. Two tails P<0.05 meant a statistical difference.

3 Results

3.1 General characteristics of the two groups

Eighteen male and 14 female DN patients with the mean age of 65.82±11.63 year were included in the control group. And there were 16 male, 14 female DN patients with the mean age of 67.24±10.81years were included in the experiment group. The mean age, gender, course of disease and serum creatinine level of the two groups were not statistical different (P>0.05), (Table 1).

Table 1

General characteristics of the two groups

AgeGenderCourse of diseaseSerum creatinine
Groups(year)(M/F)(year)(umol/L)
Control(n=32)65.82±11.6318/1410.66±4.6570.22±12.56
Experiment(n=30)67.24±10.8116/1411.74±6.2368.36±15.44

3.2 Renal function of two groups after treatment

After two weeks treatment, the serum level of CysC and UAER significantly decreased for both control and experiment group (P<0.05), (Table 2). The serum level of CysC were 1.40 ±0.46 mg/L and 1.02±0.33 for control and experiment group respectively with statistical difference (P<0.05) after treatment. The post-treatment UAER in experiment group was significant lower than those of control group with statistical difference (81.02±0.33 vs112.45±20.32, P<0.05) ug/min.

Table 2

The serum level of CysC, UAER, SCr before and after treatment for both control and experiment group

GroupCysC (mg/L)SCr(umol/L)UAER(ug/min)
Before treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatment
Control(n=32)1.78±0.511.40 ±0.46[#]70.22±12.5669.55±11.66152.11±26.88112.45±20.32[#]
Experiment(n=30)1.80 ±0.561.02±0.33 [#][*]68.36±15.4468.23± 14.55147.69±29.6581.02±0.33#[*]

3.3 Serum level of CRP, IL-6 and TNF-α

The serum level of CRP, IL-6 and TNF-α were significant decreased after treatment in both control and experiment group (P<0.05), (Table 3). And the post-treatment serum CRP, IL-6 and TNF-α in the experiment group were significantly lower than that of the control group with statistical difference (P<0.05), (Figure 1).

Figure 1 Bar plot for serum level of CRP, IL-6 and TNF-α in experiment and control group(A: serum CRP; B: serum IL-6; C: serum -TNF-α
Figure 1

Bar plot for serum level of CRP, IL-6 and TNF-α in experiment and control group(A: serum CRP; B: serum IL-6; C: serum -TNF-α

Table 3

Serum level of CRP, IL-6 and TNF-α before and after treatment for both control and experiment group

GroupCRP(mg/L)IL-6(ng/L)TNF-α(ng/L)
Before treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatment
Control(n=32)1.69 ±0.511.06±0.43[#]55.33±17.3641.20 ±16.21[#]60.60±22.2645.23±19.45[#]
Experiment(n=30)1.67±0.490.79±0.36[#][*]56.47 ±18.2227.14 ±15.27[#][*]63.21±24.7430.33±18.56[#][*]

3.4 Drug related toxicity

No obvious drug related toxicity was found in the two groups. And all the patients successfully finished the treatment plan.

4 Discussion

The exact pathogenesis of DN remains unclear. Hyperglycemia and abnormal increase levels of TNF-α [9, 10], IL-6 [11,12], and other inflammatory cytokines can damage pancreatic β cells, induce insulin resistance, and facilitate oxidative stress. As a result, a vicious cycle is formed, endothelial cells and tissues are damaged, and the permeability of glomerular basement membrane is increased. These conditions consequently cause proteinuria and trigger the onset of DN. Under hyperglycemic conditions, various factors induce the overproduction of reactive oxygen species (ROS), and ROS levels exceed the scavenging activity of antioxidants [13-16]. The accumulation of high ROS concentrations caninduce oxidative stress oninnate renal cells, activate relevant signal pathways within cells, promote the transcription and high expression of fibroblast growth factors, and stimulate the excessive deposition of extracellular matrix and renal fibrosis [9,10]. Therefore, inflammatory reaction and oxidative stress play a crucial role in the occurrence and development of DN. Inflammatory reaction inhibition and oxidative stress relief are also optimum targets for the clinical treatment of DN.

Luo et.al performed an animal study to evaluate the therapeutic effect of alprostadil in diabetic nephropathy. They found that alprostadil treatment can protect renal function by reducing proteinuria. These effects are mediated, at least in part, through down-regulation of Ang-2 and IL-18 expression [6]. However, the clinical effects of alprostadil for DN patients was seldom reported. Liu et.al evaluate the clinical efficacy of lipoicascid combined with alprostadil in the treatment of diabetic nephropathy. The results indicated that the fasting blood glucose, 24 h urine protein, blood urea nitrogen and creatinine decreased significantly in the treatment group compared with the control group [17]. In our present study, the combined treatment could significantly reduce inflammatory indexes, such asIL-6, CRP, and TNF-α, in patients who suffered from early DN. The combined treatment could also decrease UAER and CysC, a marker of early renal injury. These results indicated that alprostadil and α-lipoic acid could improve patients’ renal functions by reducing their inflammatory cytokine levels which was in accordance with Liu et.al [17]. Prostaglandin E1 serves as the main component of alprostadil. This compound can inhibit the activity of rennin-angiotensin system, dilate blood vessels, resist platelet aggregation, adjust microcirculation, increase renal blood flow, and block inflammatory cytokines to reduce urine protein content and protect the kidneys. As a well-known clinical antioxidant, α-lipoic acid can prevent oxidative stress, enhance vascular endothelial functions, reduce UAER, alleviate glomerular sclerosis and renal tubule interstitial fibrosis, maintain residual renal functions, and delay progressive renal damage in patients.

In summary, the combined alprostadil-lipoic acid treatment was more effective than single treatments in reducing inflammatory cytokine levels, inhibiting oxidative stress and protecting the kidneys of patients in early stage of DN. However, in this study all inflammatory factors significantly decreased, the benefit for the DN is not clear. The decrease of cytokines may be beneficial for DN patients but this has not definitely been proven in the present work and in previously published studies. Therefore, the detailed mechanism of this combined treatment should be further investigated.


Lejian Lan and Jianyun Peng contributed equally to this work


  1. Conflict of interest

    Conflict of interest statement: Authors state no conflict of interest.

References

[1] Kitada M, Koya D. [Epidemiology of diabetic nephropathy]. Nihon Rinsho 2012;70 Suppl 5:384-388Search in Google Scholar

[2] Kawanami D, Utsunomiya K. [Epidemiology of diabetic nephropathy]. Nihon Rinsho 2016;74 Suppl 2:153-15710.1186/s41100-016-0028-0Search in Google Scholar

[3] Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm 2012;2012:14615410.1155/2012/146154Search in Google Scholar PubMed PubMed Central

[4] Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond) 2013;124:139-15210.1042/CS20120198Search in Google Scholar PubMed

[5] Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes 2014;5:393-39810.4239/wjd.v5.i3.393Search in Google Scholar PubMed PubMed Central

[6] Luo C, Li T, Zhang C, Chen Q, Li Z, Liu J, et al. Therapeutic effect of alprostadil in diabetic nephropathy: possible roles of angiopoietin-2 and IL-18. Cell Physiol Biochem 2014;34:916-92810.1159/000366309Search in Google Scholar PubMed

[7] Yi X, Nickeleit V, James LR, Maeda N. α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy. J Diabetes Complications 2011;25:193-20110.1016/j.jdiacomp.2010.07.004Search in Google Scholar PubMed PubMed Central

[8] Cicek M, Yildirir A, Okyay K, Yazici AC, Aydinalp A, Kanyilmaz S, et al. Use of alpha-lipoic acid in prevention of contrast-induced nephropathy in diabetic patients. Ren Fail 2013;35:748-75310.3109/0886022X.2013.790298Search in Google Scholar PubMed

[9] Meng N, Zhang Y, Li H, et al. Association of tumor necrosis factor alpha promoter polymorphism (TNF-alpha 238 G/A and TNF-alpha 308 G/A) with diabetic mellitus, diabetic retinopathy and diabetic nephropathy: a meta-analysis[J]. Curr Eye Res, 2014,39(2):194-20310.3109/02713683.2013.834942Search in Google Scholar PubMed

[10] Gupta S, Mehndiratta M, Kalra S, et al. Association of tumor necrosis factor (TNF) promoter polymorphisms with plasma TNF-alpha levels and susceptibility to diabetic nephropathy in North Indian population[J]. J Diabetes Complications, 2015,29(3):338-34210.1016/j.jdiacomp.2015.01.002Search in Google Scholar PubMed

[11] Svensson MK, Eriksson JW. Change in the amount of body fat and IL-6 levels is related to altered insulin sensitivity in type 1 diabetes patients with or without diabetic nephropathy[J]. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2011,43(3):209-21510.1055/s-0031-1271622Search in Google Scholar PubMed

[12] Rakitianskaia IA, Riabov SI, Dubrova AG, et al. [The role of IL-6 in the development of morphological changes in renal tissue in elderly patients with type 2 diabetes complicated by diabetic nephropathy][J]. Advances in gerontology = Uspekhi gerontologii / Rossiiskaia akademiia nauk, Gerontologicheskoe obshchestvo, 2012,25(4):632-637Search in Google Scholar

[13] Kohan DE. Reactive oxygen species and endothelins in diabetic nephropathy. J Lab Clin Med 2000;135:300-30210.1067/mlc.2000.105972Search in Google Scholar PubMed

[14] Reactive Oxygen Species and Diabetic Nephropathy. Proceedings of the Hyonam Kidney Laboratory, Soon Chun Hyang University International Diabetes Symposium. Seoul, Korea, January 18-19, 2003. J Am Soc Nephrol 2003;14:S209-29610.1097/01.ASN.0000077403.06195.D2Search in Google Scholar

[15] Ha H, Hwang IA, Park JH, Lee HB. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 2008;82 Suppl 1:S42-4510.1016/j.diabres.2008.09.017Search in Google Scholar PubMed

[16] Bondeva T, Wolf G. Reactive oxygen species in diabetic nephropathy: friend or foe. Nephrol Dial Transplant 2014;29:1998-200310.1093/ndt/gfu037Search in Google Scholar PubMed

[17] Y Liu, S Dong, X Yang, S Jing, X Wang.Clinical Efficacy of Lipoic Acid Combined with alprostadil in the treatment of Diabetic Nephropathy. China Continuing Medical Education 2016;8:153-154Search in Google Scholar

Received: 2017-4-13
Accepted: 2017-8-6
Published Online: 2017-10-5

© 2017 Yan Hong et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
Downloaded on 25.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/med-2017-0046/html
Scroll to top button